sun pharma
Sun will be responsible for development, regulatory filings and manufacturing of the drugs, while AstraZeneca will exclusively promote and distribute the products in China, according to a filing here to Indian stock exchanges.
AstraZeneca to distribute Sun Pharma cancer medicines in China
06 Nov 2019 12:47 PM

Shares of Sun Pharma rose as much as 5.4 per cent to a nine-week high after the announcement.

Shares of Sun Pharmaceutical Industries closed at Rs 431.95 per scrip on the BSE, up 1.30 per cent from its previous close.
Sebi orders forensic audit of Sun Pharma financial statements from FY16-18
07 Sep 2019 12:08 PM

Sun Pharma, however, did not provide any specific details on the reasons for the SEBI to order the forensic audit.

Under terms of the license agreement, CMS will pay Sun Pharma an initial upfront payment, regulatory and sales milestone payments, and royalties on net sales.
Sun Pharma, China Medical System Holdings enter into two license agreements
28 Jun 2019 11:09 AM

The initial tenure of the agreement shall be 15 years from the first commercial sale of CsA in Greater China.

  • « First
  • « Previous
  • 1
  • Next »
  • Last »

1 of 1